NCT04166734 2026-02-04MESO-PRIMERoyal Marsden NHS Foundation TrustPhase 1 Terminated5 enrolled 13 charts
NCT05070247 2026-01-22A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsTakedaPhase 1/2 Terminated61 enrolled 29 charts
NCT03075527 2026-01-08A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural MesotheliomaDana-Farber Cancer InstitutePhase 2 Terminated19 enrolled 12 charts
NCT04272034 2025-10-16Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsIncyte CorporationPhase 1 Terminated105 enrolled
NCT06336148 2025-10-15A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsActym Therapeutics, Inc.Phase 1 Terminated10 enrolled
NCT02613299 2025-07-14Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural MesotheliomaMayo ClinicTerminated5 enrolled
NCT03975387 2025-04-09Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53Taiho Oncology, Inc.Phase 1 Terminated106 enrolled